F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Start

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Previous Story

Meta to Pay Up to $17.1 Billion in Landmark Settlement Over Social Media Addiction Claims